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numerous molecular mechanisms. Key components of the
regulatory network underlying heart development are tran-
scription factors (TFs) and microRNAs (miRNAs), yet limited
investigation of the role of miRNAs in heart development has
taken place. Here, we report the ﬁrst parallel genome-wide
proﬁling of polyadenylated RNAs and miRNAs in a developing
murine heart. These data enable us to identify dynamic activa-
tion or repression of numerous biological processes and
signaling pathways. More than 200 miRNAs and 25 long
non-coding RNAs were differentially expressed during embry-
onic heart development compared to the mature heart; most of
these had not been previously associated with cardiogenesis.
Integrative analysis of expression data and potential regulatory
interactions suggested 28 miRNAs as novel regulators of em-
bryonic heart development, representing a considerable expan-
sion of the current repertoire of known cardiac miRNAs. To
facilitate follow-up investigations, we constructed HeartMiR
(http://heartmir.sysbiolab.eu), an open access database and
interactive visualization tool for the study of gene regulation
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Heart development comprises a series of temporally and spatially co-
ordinated processes, involving distinct cell populations.1 In mice, a
primitive linear heart tube is formed from the lateral mesoderm at
embryonic day 8 (E8.0). As the embryo continues to develop, cham-
ber formation and septation lead to formation of a functional four-
chambered heart.2 Key cardiac transcription factors (TFs), including
Tbx5, Nkx2-5, Gata4, Isl1, and Mef2c, have been identiﬁed and their
roles in heart development extensively studied (for review, see Mega-
nathan et al.8).3–8 These TFs form a conserved network and drive
differentiation of cardiac progenitor cells toward cardiomyocytes,
cardiac endothelial cells, and other cell types that constitute a func-
tional heart. In addition, extrinsic signaling molecules, such as bone158 Molecular Therapy: Nucleic Acids Vol. 12 September 2018 ª 2018
This is an open access article under the CC BY license (http://creatimorphogenic proteins (BMPs) in the anterior lateral plate mesoderm,
are essential for the initiation of myocardial differentiation and car-
diac developmental processes.9 More recently, small non-coding
RNAs, termed microRNAs (miRNAs) have been recognized as key
regulators of organ development in several organisms, such as Caeno-
rhabditis elegans, Drosophila melanogaster, and humans.10–13
miRNAs (21–25 nt in length) commonly regulate gene expression at
post-transcriptional level through imperfect base pairing to target
mRNAs,14 leading to translational inhibition and mRNA degrada-
tion.15 Formation of mature miRNAs occurs in four steps: (1) tran-
scription of a primary miRNA (pri-miRNA) via RNA polymerase
II; (2) processing of the pri-miRNA by Drosha (a RNase III type
endonuclease) and the double-stranded RNA binding protein
DGCR8 (DiGeorge syndrome critical region gene 8) complex to pro-
duce a hairpin precursor miRNA (pre-miRNA), consisting of 70 nt
in the nucleus; (3) export of the pre-miRNA to the cytosol via the pro-
tein exportin-5; and (4) cleavage by Dicer (a the RNase III type endo-
nuclease) to produce 22-bp double-stranded miRNA. Following
this ﬁnal step, one strand is typically degraded, whereas the other
strand is integrated into the RNA-induced silencing complex
(RISC). The RISC complex targets complementary sequences in the
mRNAs that are mainly located in the 30 UTR but can also be found
in the 50 UTR and coding region, resulting in degradation of the
mRNA or inhibition of its translation.13The Author(s).
vecommons.org/licenses/by/4.0/).
www.moleculartherapy.orgA number of studies have suggested crucial roles for miRNAs in
heart development and function. For instance, overexpression of
miR-1 in a developing mouse heart inhibits proliferation of ventric-
ular cardiomyocytes, causing developmental arrest at E13.5, as a
result of thinning of the ventricle walls and heart failure.14 Mean-
while, overexpression of the miR-17-92 cluster induced proliferation
of both neonatal and adult cardiomyocytes. Overexpression of this
miRNA cluster in adult cardiomyocytes also protected the heart
from myocardial-infarction-associated injury, potentially through
reducing the expression of phosphatase and tensin homolog
(Pten)—a proliferation repressor.16 Moreover, miRNA dysregula-
tion has been associated with various cardiac events, inﬂuencing
myocardial structure, contractility, ﬁbrosis, and apoptosis.17 Despite
evidence of the impact of miRNAs on heart development and func-
tional integrity, no comprehensive proﬁling of their expression dur-
ing cardiogenesis has been undertaken to date. To address this
salient lack of knowledge, we performed parallel genome-wide
proﬁling of miRNAs and polyadenylated [poly(A)]-RNAs from
developing hearts of mice embryos from E10.5 until E19.5, as well
as from mature hearts of young and old adult mice. Proﬁles of
poly(A)-RNA and miRNA were analyzed independently, and their
differential expression was determined. Gene clustering analysis
revealed a distinct temporal activation during the developmental
processes, indicating speciﬁc genes involved in cardiogenesis. Inte-
grative analysis of gene expression proﬁles and gene targets led to
prioritization of 27 miRNAs as novel potential regulatory factors
of heart development. Finally, an open access database and interac-
tive visualization tool, called HeartMiR (http://heartmir.sysbiolab.eu),
was developed to identify (anti-) correlated expression patterns of
miRNAs and their target genes during heart development and in
mature heart tissue. This database provides a resource for cardiac
gene regulation by miRNAs and a basis for further investigation
of heart development, congenital heart diseases, or cardiac regener-
ative medicine.
RESULTS
Parallel Profiling of the poly(A)-RNA andmiRNA Transcriptomes
To assess dynamic expression of poly(A)-RNA and miRNA during
murine heart development in vivo, tissue samples from embryonic
hearts were taken each day from E10.5 to E19.5 (Figure 1A). For com-
parison, we also collected samples from young and old adult hearts.
Microarray experiments were performed for triplicate biological sam-
ples of both poly(A)-RNA and miRNA. Notably, heart tissue was
dissected from both male and female embryos and adults to identify
any gender-speciﬁc effects on gene expression. Seventy-two samples
were proﬁled using Affymetrix Mouse Genome 430 2.0 Arrays and
Affymetrix miRNA 3.0 GeneChips. Although the majority of probes
on the Affymetrix Mouse Genome platform target mRNAs, this plat-
form also included probes against numerous long non-coding RNAs
(lncRNAs).
For both poly(A)-RNAs and miRNAs, clustering of the full microar-
ray proﬁles was carried out. In general, samples from the same
developmental status were grouped, suggesting a robust temporalexpression signature (Figure S1). Expression proﬁles of young and
old adult hearts formed a distinct cluster. Similar patterns also
emerged through principal-component analysis (PCA). Global
expression during development (E10.5–E19.5) gradually approxi-
mated the mature heart, although a clear segregation of embryonic
and mature samples remained (Figures 1B and 1C). This indicates
substantial differences in expression between developing and mature
cardiac tissue. Interestingly, the distribution of poly(A)-RNA levels
for E10.5–E13.5 showed a notable “shoulder,” suggesting an underly-
ing bimodal distribution, whereas samples from later time points dis-
played a gradual decrease in the number of genes with high expression
values (Figure S2). Such bimodality might suggest a greater tendency
toward an “on or off” mode of expression during early development,
with more gradual adjustment during later stages of development.
Genes Linked to Heart Development and Function ShowDistinct
Expression Changes
To detect differentially expressed genes (DEGs) transcripted as
poly(A)-RNAs, normalized Affymetrix GeneChip signal intensities
of various developmental stages were compared with intensities for
young adult hearts. Because a large number of genes displayed
changes in expression, a very stringent threshold for differential
expression was set, using an adjusted p value of%105 and an abso-
lute log2 fold change of R2 (4-fold change). Collectively, we found
2,708 non-redundant genes to be differentially expressed for at least
one time point. These represent 13% of the genes covered by the array.
Notably, the number of DEGs reduced drastically with ongoing devel-
opment, reducing to 2,080 at E10.5 and further to 495 at E19.5 (Fig-
ure 1D). DEGs at each time point are listed in Table S1. To evaluate
the dynamics of gene expression during cardiogenesis, we initially in-
spected the transcript levels of genes associated with heart develop-
ment in Gene Ontology (GO: 0007507; Table S2). TFs essential for
heart development, such as Gata3, Gata4 (Figure 2A), Nkx2-5, and
Hand2, were gradually downregulated during embryonic develop-
ment, whereasMyocd (transcriptional co-activator of serum response
factor) displayed an initial increase in expression but plateaued from
E15.5 to E18.5 (Figure 2B). All these TFs were only weakly expressed
in mature hearts. Expression of Foxc1, Foxc2, and Foxp1 of the fork-
head family of TFs, known to play an important role in embryonic
heart development,18 decreased with progressive development, reach-
ing lowest levels in adult tissue (Figure 2C). Consistent with the estab-
lished role of BMPs in transforming growth factor beta and Wnt
signaling pathways during cardiac development,9 the expression of
Bmp2, Bmpr1a (bone morphogenetic protein receptor type 1A),
Tgf-b, and Wnt5a was downregulated over time (Figure 2D). Next,
we inspected expression of genes associated with contraction of car-
diac muscle, affecting the primary function of the heart (Figure 2E).
Strikingly, cardiac alpha actin gene (Actc1), a known marker for early
myogenesis,19 had the highest signal intensity of all genes at E10.5 but
was subsequently downregulated, having minimum expression in the
adult heart. Likewise, Myh7, which encodes for the b-myosin heavy
chain, was highly expressed at all developmental stages but weakly
expressed in adult hearts. This ﬁnding is consistent with previous
observations of postnatal downregulation ofMyh7 in mice and otherMolecular Therapy: Nucleic Acids Vol. 12 September 2018 159
Figure 1. Experimental Design, Principal-
Component Analysis of Transcriptome Data, and
Number of Differentially Expressed Genes and
miRNAs
(A) Tissue samples from the developing heart at time
points from E10.5 to E19.5, as well as from young and old
adult hearts, were taken, and the extracted RNA was
analyzed by microarray experiments. (B) Principal-
component analysis of the expression of genes coding for
poly(A)-RNA is shown. (C) Principal-component analysis
of miRNAs is shown. (D and E) Number of differentially
expressed genes (D) and miRNAs (E) in developing heart
and older adult heart tissues, compared with young
mature heart tissue, is shown. (F and G) Number of
differentially expressed genes (F) and miRNAs (G) in
developing heart and older adult heart tissues, compared
with E19.5 heart tissue, is shown.
Molecular Therapy: Nucleic Acidsrodent hearts.20 In contrast, the expression of cardiac troponin I
(Tnni3) was gradually upregulated during development, with
maximum expression occurring in mature hearts. An even more
extreme case, showing almost switch-like upregulation, was observed
for titin-cap (Tcap), linked to sarcomere assembly. Throughout most
of the monitored developmental stages, it was expressed at marginal
levels but began to accumulate at E19.5 only and was more than
10-fold upregulated in adult hearts. We also investigated expression160 Molecular Therapy: Nucleic Acids Vol. 12 September 2018in epigenetic regulators. In particular, expres-
sion of histone deacetylase 2 (Hdac2) strongly
reduced in a linear manner during development,
exhibiting a greater than 10-fold change (Fig-
ure 2F). Hdac2 deacetylates lysine residues at
the N-terminal regions of the core histones
H2A, H2B, H3, and H4, playing an important
role in transcriptional regulation and plas-
ticity.21 Table S3 indicates differentially ex-
pressed genes associated with the activity of
ion channels in GO identiﬁed in our study.
Close scrutiny suggests that ion channels un-
dergo major remodeling during cardiac devel-
opment. For instance, Cacna1h and Cacna2d2
encoding for the a1- and a2-d subunits of
voltage-gated calcium channels, respectively,
were gradually downregulated during develop-
ment and were expressed at relatively low levels
in adult hearts. In contrast, the gene Cacna1g,
which is a paralog of Cacna1h that encodes for
an alternative a1 subunit, was initially upregu-
lated, reaching a maximal plateau during late
developmental stages (Figure 2G). Among the
genes corresponding to sodium channels, we
found that the a subunit encoded by the Scn7a
gene remained very weakly transcripted in em-
bryonic hearts but had up to 10-fold higher
expression in mature hearts, displaying aswitch-like expression pattern (Figure 2H). The genes for potassium
channels, Kcna5 and Kcnb1, were very lowly expressed in all develop-
mental stages but induced in both young and old adult hearts (Fig-
ure 2I). In contrast, transcripts of Kcne1 gradually accumulated
during development but were markedly depleted in adult hearts (Fig-
ure 2J). Expression of Kcnq5 tended to be more strongly repressed
as development occurred, whereas expression of Kcna4 showed
a parabolic expression pattern, with maximal expression at E15.5
Figure 2. Temporal Expression Profiles of Selected
Genes with Existing Association with Heart
Development and Ion Channel Function
(A) Gata transcription factors (TFs). (B) Known key TFs for
cardiogenesis are shown. (C) Fox family TFs are shown.
(D) Signaling pathway molecules linked for cardiac
development are shown. (E) Genes encoding for structural
cardiac proteins are shown. (F) Histone deacetylase is
shown. (G) Calcium channel genes are shown. (H) Sodium
channel gene is shown. (I and J) Potassium channel genes
upregulated (I) and downregulated (J) in young mature
heart tissue are shown. (K) Chloride channel genes are
shown. (L) Cell cycle genes are shown. Dotted lines were
plotted between E19.5, young, and old adult stages to
emphasize the largely increased time intervals between
these time points compared to the previous time points.
www.moleculartherapy.org(Figure 2J). A remarkable transcriptional plasticity was also observed
for chloride (Cl) channels. Expression of Clinc5 progressively
decreased between E10.5 and E19.5, resulting in very low levels in
adult hearts (Figure 2K). A transient pattern was observed for
Clca3a1.After an initial increase from E10.5 to E13.5, an almost stable
expression level was maintained until E19.5 before a drastic reduction
occurred, yielding very low levels in both young and old adult hearts.
In contrast,Clic5, which encodes for a chloride channel located in car-
diomyocyte mitochondria of different rodents,22 displayed a linear in-
crease in expression during development, with a considerable boost in
expression in adult heart tissue. Finally, the transcript level of cell di-
vision cycle (Cdc) genes, such as Cdc27, Cdc20, and Cdca3, decreased
during embryonic development and were further reduced in matureMolecular Therapcardiac tissue, reﬂecting the ceasing of cell cycle
activity with progressing heart development.
Interestingly, we found that Rgcc (regulator of
cell cycle) displayed a contrasting pattern with
low transcript levels during earlier development
but high levels in adult heart. This suggests that
Rgcc might contribute to postnatal cell cycle ar-
rest in cardiomyocytes.
To assess the reliability of the generated tran-
scriptomics data, we compared them with those
reported in a related microarray study of mu-
rine heart development.23 A cross-correlation
analysis veriﬁed both time series studies were
in concordance on the transcriptome level (Sup-
plemental Information; Figure S3).
Gene Expression of Transcripts of
Unknown Function during the Heart
Development and Adult Heart
We were especially interested in genes listed as
Riken genes or predicted in the Mouse Genome
Informatic (MGI) database. The former origi-nate from sequencing of full-length cDNA libraries collected at the
Riken Institute, and many of these remain poorly characterized. In
our study, we found 127 Riken and predicted genes among the
DEGs. After removal of genes functionally annotated in GO, 107
DEGs remained (Table S4). Remarkably, almost a quarter (23%)
was curated as (long) non-coding RNA genes in the MGI database.
We assigned protein-coding Riken and predicted genes to three
classes, based on whether their expression patterns showed (1) a
gradual decrease in expression over time (29 genes; Figure 3A);
(2) a transient higher expression during development (37 genes; Fig-
ure 3B); or (3) a gradual increase in expression over time (16 genes;
Figure 3C). A particularly strong increase of over 6-fold change andy: Nucleic Acids Vol. 12 September 2018 161
Figure 3. Differentially Expressed Genes Encoding for Poly(A)-RNA without Current Functional Annotation
(A–C) Protein-coding genes with decreased (A), transient (B), or increased (C) expression. (D–F) Non-coding genes with decreased (D), transient (E), or increased (F)
expression during embryonic development are shown.
Molecular Therapy: Nucleic Acidsa high absolute expression level at E15.5 was recorded for
1110002E22Rik. This was also one of the few Riken genes, for which
a putative protein domain was detected. Close to the C terminus, a
histone deacetylase superfamily domain (IPR000286) was predicted
by Interpro, providing an interesting clue to the function of
1110002E22Rik.
Similarly, the differentially expressed non-coding genes were
grouped into three classes, reﬂecting their expression patterns. In
this case, six genes were downregulated during development (Fig-
ure 3D) and ten genes displayed transiently higher expression (Fig-
ure 3E), whereas nine genes were gradually induced (Figure 3F).
Two lncRNAs showed an especially strong increase in expression
during development: Riken A130040M12 (29-fold) and Gm20186
(10-fold). The former has a 3,366-nt transcript derived from
Viral-like 30 elements (VL30s). The later leads to a 741-nt tran-
script and was detected as widely expressed across multiple organs
in mouse embryos by in situ hybridization (MGI-Gene Expression
database). The expression of lncRNAs increased in old compared
with young adult hearts. A similar expression pattern was found
for Braveheart, an lncRNA that was recently shown to modulate
the expression of cardiac TFs. Whereas Braveheart was not
included in the list of DEGs because of our stringent threshold,
its previously reported expression is consistent with our data.24
In our study, Braveheart displayed low transcript levels during
developmental stages but was two-fold upregulated in mature heart162 Molecular Therapy: Nucleic Acids Vol. 12 September 2018tissue (Figure 3F). A more transient expression pattern was
observed for 4632404M16Rik (Figure 3E), which is an intronic
lncRNA of 2,882 nt length. It initially follows the upregulation of
cardiac calsequestrin 2 (Casq2), in which 4632404M16Rik is
located. CASQ2 is the most abundant Ca2+-binding protein in
the sarcoplasmic reticulum and integral to the high Ca2+ capacity
of the sarcoplasmic reticulum. Although Casq2 remained highly ex-
pressed after development, 4632404M16Rik expression was only
weak in mature tissue, suggesting that its function is evoked mainly
during cardiogenesis (Figure S4).
Genes Expressed in an Age- or Gender-Dependent Manner
PCA and clustering analysis (Figures 1B and S1) indicate that gene
expression in the hearts of older adult mice (10 months old) closely
resembles that in hearts of younger adult (10 weeks old) mice. Only
seven genes were found to be differentially expressed (Table S1).
The most upregulated gene in older hearts was Adamts9, which is a
member of the ADAMTS (a disintegrin and metalloproteinase with
thrombospondin motifs) family. It encodes for a secreted protease,
acting as an angiogenesis inhibitor.25 The most downregulated gene
was the coiled-coil domain containing 141 (Ccdc141).
Over our time series, only three genes were consistently differentially
expressed between male and female tissue samples. As expected, Xist
was detected only in female samples, whereas Eif2s3y andDdx3y, both
located on the Y chromosome, were detected only in male samples.
Figure 4. Temporal Expression Profiles of Selected DEmiRs for Embryonic
and Mature Heart Tissues
www.moleculartherapy.orgClearly, the extent of gender-speciﬁc expression was marginal during
development, although we observed signiﬁcantly larger variability in
expression between male and female samples in adult samples, espe-
cially in older mature heart tissue (Figure S5). The number of genes
having more than a 2-fold expression change between male and fe-
male samples increased from ﬁve at E19.5 to thirty in adult tissue
and up to 98 in older mature tissue (Table S5). Of these, 55 genes
were upregulated and 43 were downregulated in male heart tissue.
A GO enrichment analysis of these upregulated genes showed signif-
icant overrepresentation of cytoskeletal genes, especially those associ-
ated with actin ﬁlament and organization. The most upregulated gene
was gelsolin, which encodes for a protein regulating the actin cyto-
skeleton. In contrast, no enriched GO categories were associated
with downregulated genes.
Differential miRNA Expression during Heart Development
The same method and thresholds for DEGs were used to identify
differentially expressed miRNAs (DEmiRs). We identiﬁed 217
DEmiRs in this study. Similar to DEGs, the number of DEmiRs grad-
ually decreased from 191 at E10.5 to 98 at E19.5, as heart develop-
ment progressed (Table S6; Figure 1E). Comparing the number of
upregulated and downregulated DEmiRs, we found 2.5–3.5 times
more upregulated than downregulated DEmiRs during heart devel-
opment. This contrast with the ratio of upregulated to downregu-
lated DEGs, which is more balanced in later stages of development
(Figure 1D). Among the DEmiRs, we identiﬁed a number of
miRNAs associated with the cardiac cell lineage, including miR-17,
miR-29-3p,26,27 miR-199a-3p,28,29 miR190-3p,30 and miR-1.31–33
The expression of miR-17-5p was gradually downregulated from
E10.5 to E19.5, with a subsequent 3-fold drop in expression in adult
heart tissue (Figure 4). In contrast, the expression levels of miR-
29a-3p, miR-195a-5p, and miR-1a were relatively low during all
developmental stages but highly upregulated in adult hearts. More
transient expression patterns were displayed by miR-199a-3p and
miR-133a, for which we recorded maximum and minimum signal
intensities at developmental stages of E12.5 or E13.5, respectively.
As in the case of poly(A)-RNAs, we searched for differentially ex-pressed miRNAs in older versus younger adult heart tissue, as well
as for gender-speciﬁc changes. However, no signiﬁcant differential
expression was detected in these comparisons.
Dynamics of Gene Expression during Embryonic Heart
Development
Our approach to use the young heart tissue as reference delivered a
large number of genes that were differentially expressed in embry-
onic compared to mature tissue. To demarcate genes that showed
signiﬁcant expression changes during the embryonic development,
we reanalyzed the transcriptomic with E19.5 as new reference. As
shown in Figures 1F and 1G, the number of the newly detected
DEGs and DEmiRs rapidly decreased in the early stages of the devel-
opment (E10.5–14.5) in exponential manner. Compared to the
higher large numbers of genes and miRNAs observed in the previous
comparison (Figures 1D and 1E), the numbers of genes and miRNAs
with signiﬁcant dynamic expression during development were
considerably smaller. In particular, only a few genes and no miRNAs
were found differentially expressed for E15.5–E18.5. Analyzing the
expression in mature tissue with E19.5 as reference conﬁrmed the
striking imbalance between positively and negatively regulated
miRNAs. We identiﬁed 3.5 times more negatively regulated than
positively regulated miRNAs in mature tissue when compared to
E19.5. Tables S7 and S8 list the genes that were found differentially
regulated at the different heart developmental stages using the E19.5
heart developmental stage as a reference in comparison to young
adult heart applied as a reference, respectively. Tables also show
commonly differential expressed genes and miRs identiﬁed by
applying the adult and E19.5 developmental stage as references.
Moreover, we have also identiﬁed non-uniquely and uniquely genes
(Table S9) and miRs (Table S10) that were expressed for each devel-
opmental stage.
Integrative Analysis of Dual Transcriptome Data and miRNA
Gene Targets
To obtain comprehensive coverage of potential miRNA targets, we
integrated miRNA interactions from ﬁve independent resources
(see Materials and Methods). Stringent ﬁltering procedures were
applied to predicted miRNA interactions to reduce the number
of false positives (see Supplemental Information). We only
included interactions in which the miRNA or its target was ex-
pressed at least at one time point in this study. This led to compi-
lation of 102,083 potential interactions between 368 miRNA and
9,211 gene targets, covered by our microarray platforms. To cope
with this complexity and evaluate major expression trends, we clus-
tered the DEGs and DEmiRs separately, based on their standard-
ized expression proﬁles using fuzzy c-means clustering.34 This
resulted in the detection of six clusters of DEGs and three clusters
of DEmiRs. Each possible pair of clusters of DEGs and DEmiRs
was subsequently evaluated for putative miRNA-gene interactions
to derive a regulatory interaction matrix (Mall). Because miRNAs
are commonly considered to be post-transcriptional repressors,
we also determined an interaction matrix Mneg, which included
only anti-correlated interactions between miRNAs and theirMolecular Therapy: Nucleic Acids Vol. 12 September 2018 163
Figure 5. Integrative Analysis of Clusters of DEmiRs
and DEGs
The fuzzy c-means algorithm was used to obtain three
DEmiR clusters and six DEG clusters. Clusters were linked
based on miRNA-target gene interactions. Links are only
displayed when dominated by negatively correlated
miRNAs and target gene interactions. The tables in the
bottom panel display the total number of potential regu-
latory interactions between pairs of DEmiR and DEG
clusters (Mall) and the number of interactions between
negatively correlated miRNAs and target genes (Mneg).
The width of the arrow indicates the number of anti-
correlated targeted genes.
Molecular Therapy: Nucleic Acidstarget genes. In this way, we combined our clustering approach and
interaction data to generate a compact network of miRNA and
gene clusters displayed in Figure 5, together with the regulatory
interaction matrices Mall and Mneg. Given that, in classical models,
miRNA binding leads to repression of their targets, we focused on
the links between DEmiR and DEG clusters, in which putative
negative regulatory interactions dominated.
DEmiRs in cluster 1 were strongly downregulated in mature heart
tissue compared with samples of developing hearts. Only minor dif-
ferences in their expression levels were observed between stages of
embryonic development. Compared with DEmiR cluster 1, DEG
cluster 1 showed the strongest anti-correlation in expression.
Accordingly, DEG cluster 1 showed little change in gene expression
from E10.5 to E19.5 but a considerable increase in mature tissue.
Remarkably, miRNAs of DEmiR cluster 1 targeted 241 of the 643
genes included in DEG cluster 1. We also detected signiﬁcant
enrichment of target genes among biological processes associated
with metabolism, such as oxidation-reduction processes (false
discovery rate [FDR] = 2.0E5) and the immune system
(FDR = 0.009).
DEmiR cluster 2 showed a gradual decrease in expression during em-
bryonic development and further downregulation in mature heart tis-
sue. These changes in expression levels suggest a dynamic adjustment
of the regulatory function of miRNAs included in DEmiR cluster 2
during embryonic development and are in contrast to miRNAs
included in DEmiR cluster 1, which showed little expression change
over this period. DEG cluster 2 displayed anti-correlated gene expres-164 Molecular Therapy: Nucleic Acids Vol. 12 September 2018sion behavior with DEmiR cluster 2, having a
gradual increase in gene expression during em-
bryonic heart development and further upregu-
lation in mature tissue. Notably, a large number
of genes in DEG cluster 2 were targeted by
miRNAs in DEmiR cluster 2, i.e., 198 out of
517 genes. Further functional enrichment anal-
ysis of the targeted genes in DEG cluster 2
revealed a signiﬁcant association with develop-
mental biological processes, including angio-genesis (FDR = 3.7E5) and cardiovascular system development
(FDR = 9.9E6).
Finally, the expression of most miRNAs in DEmiR cluster 3 increased
only during embryonic heart development but reached high expression
levels in mature hearts. DEG clusters 3, 4, 5, and 6 showed the opposite
pattern of gene expression over time, comprising genes with decreasing
expression during heart development and minimum expression in
young and old adult hearts. Members of DEmiR cluster 3 targeted
188 genes belonging to DEG cluster 3, 365 genes of DEG cluster 4,
338 genes ofDEGcluster 5, and267 genes ofDEGcluster 6.GOanalysis
of the targeted DEGs from clusters 3, 4, 5, and 6 indicated statistically
enrichedbiological processes, such as regulation of gene expression, cell
cycle (FDR = 7.3E5), heart development (FDR = 2.8E5), and cyto-
skeleton organization (FDR = 0.0006). These results suggest that mem-
bers of cluster 3 DEmiRs act as key regulators of cardiogenesis, given
their potential to induce progressive downregulation of genes that
were especially active during development and postnatal maturation.
Alternative to the data-driven clustering approach connecting the
temporal proﬁles of DEGs and DEmiRs, we also aimed to link indi-
vidual miRNAs to speciﬁc genes that are known to be involved in
heart development and that we examined earlier (Figure 2). To this
end, we searched for miRNAs that target these genes and show
anti-correlated expression during embryonic development. We
excluded mature samples in the calculation of correlation to avoid
confounding effects through large postnatal expression changes that
frequently were observed. Table 1 displays anti-correlated miRNAs
that target genes in the speciﬁc sub-categories shown in Figure 2.
Table 1. Highly Anti-correlated miRs to the Specific Gene Subcategories in
Figure 2
Kendall Dev
Gata TFs
Gata4
miR-3474 0.4
miR-22-5p 0.26
Gata3
miR-27a-3p 0.64
miR-34a-5p 0.4
Cardiac TFs
MyoCD
miR-495-3p 0.6
miR-31-3p 0.54
Hand2
miR-671-5p 0.26
miR-181a-5p 0.18
Nkx2-5 miR-207 0.02
Forkhead TFs
Foxc1
miR-133b-3p 0.56
miR-680 0.46
Foxc2
miR-133a-3p 0.61
miR-133b-3p 0.61
Foxc3 – –
Signalling
Tgfb2
miR-301a-3p 0.57
miR-193b-3p 0.52
Wnt5a
miR-378a-5p 0.71
miR-378b 0.66
Bmp2
let-7b-5p 0.48
miR-27a-3p 0.44
Bmpr1a
miR-194-5p 0.72
miR-362-3p 0.46
Contraction
Myh7 – –
Actc1
miR-30a-5p 0.46
miR-30e-5p 0.44
Tnni3 – –
Tcap
miR-128-3p 0.23
miR-324-3p 0.17
Hdac
Hdac2 – –
Ca2+ Channels
Cacna2d2
miR-490-3p 0.67
miR-671-5p 0.13
Cacna1h
miR-28a-3p 0.63
miR-466a-3p 0.6
Cacna1g
miR-139-5p 0.78
miR-187-3p 0.69
Table 1. Continued
Kendall Dev
Na+ Channel
Scn7a – –
K+ Channel
Kcna5 miR-450b-3p 0.2
Kcnb1
miR-409-3p 0.8
miR-17-5p 0.6
Kcnq5
miR-292-5p 0.54
miR-324-3p 0.41
Kcne1
miR-466g 0.55
miR-466f-3p 0.42
Kcna4
miR-193b-3p 0.46
miR-181a-5p 0.12
Cl Channel
Clcn5
miR-27a-3p 0.62
miR-194-5p 0.58
Clca3a1 – –
Clic5
miR-182-5p 0.53
miR-485-5p 0.45
Cell Cycle
Cdc27
miR-362-5p 0.46
miR-195a-5p 0.45
Cdca3 miR-195a-5p 0.48
Cdc20 – –
Rgcc – –
www.moleculartherapy.orgFor the majority of inspected genes, potential regulatory miRNAs
with a moderately or strongly anti-correlated expression could be
identiﬁed. However, we did not ﬁnd indications that the samemiRNA
targets different genes of the same functional sub-categories. Further
inspection of the role of the identiﬁed miRNAs in regulating heart
developmental genes is vindicated.
Temporal Expression of DEmiRs in E10.5–E19.5 Mouse Embryos
It should be noted that the inclusion of mature samples had an impact
on the clustering (Figure 5). This appeared to be especially relevant for
the clustering of DEmiRs. All three clusters displayed strong changes
in expression between E19.5 and young mature stage, which could
dominate more subtle changes during the embryonic period. There-
fore, we carried out the clustering of DEmiRs without the expression
for the mature tissues. This led to the detection of three new clusters
(Figure 6, lower panels), which showed indeed more distinguished
expression patterns during embryonic development as compared to
the analysis including the mature tissues (Figure 6, upper panels; the
same clusters as indicated in Figure 5A). The ﬁrst cluster consisted
of gradually downregulated miRs, whereas upregulated miRs were
assigned to the second and the third clusters that showed distinct pat-
terns. In the second cluster, we found miRs that were graduallyMolecular Therapy: Nucleic Acids Vol. 12 September 2018 165
Figure 6. Clusters of Temporal Expression Profiles of DEmiRs for Embryonic and Mature Heart Tissues (Upper Panel) and for Only Embryonic Tissues
(E10.5–E19.5) (Middle Panel)
For cluster analysis, the fuzzy c-means algorithm was used to obtain three DEmiR clusters for each of the cases. The table below shows the numbers of common DEmiRs
between the two clusterings. To indicate the redistribution of DEmiRs, the coloring of the first clustering (with red for cluster 1 DEmiRs, blue for cluster 2 DEmiRs, and green for
cluster 3 DEmiRs) was kept in the second clustering. DEmiRs are labeled by the light gray color in the second clustering if they were not included in the first clustering but only
found with E19.5 as reference time point. The number of these DEmiRs is also included in the table. The DEmiRs belonging to the six clusters are also included in Table S6
(worksheet-cluster distribution).
Molecular Therapy: Nucleic Acidsupregulated, whereas the third cluster included miRs that showed the
largest increase in expression at early time points and stable expression
at later time points of the embryonic development.
Prioritization of miRNA Candidates Involved in Heart
Development and Maturation
Our microarray experiment revealed a surprisingly large number of
DEmiRs, with the vast majority of them not yet linked to heart devel-
opment or cardiac tissuematuration. To assist prioritization for future
studies of their functional relevance, we used several complementary
approaches: (1) analysis of the correlation between miRNAs and their
targets; (2) evaluation of the existing functional annotation of the tar-
gets; and (3) template-based detection of relevant miRNAs. More spe-
ciﬁcally, we classiﬁed target genes of miRNAs as negatively correlated
if the Kendall’s correlation coefﬁcient of the miRNA and target gene
was smaller than 0.4. Target genes were also classiﬁed as associated
with heart development or with transcriptional regulation based on
their current GO annotation. These data can be found in Table S11.166 Molecular Therapy: Nucleic Acids Vol. 12 September 2018Assuming that the dominant mode of miRNAs is post-transcriptional
repression, we would expect that target genes show a negative corre-
lation with miRNA expression proﬁles. Conversely, we can evaluate
the regulatory activity of a miRNA by calculating how many of its
differentially expressed target genes (DETGs) are negatively corre-
lated (DETGNCs). Plotting DETGs and DETGNCs (Figure 7A)
clearly showed that many of the miRNAs having a high percentage
of negatively correlated target genes are already known to be involved
in the regulation of heart development or function. For instance, at
least 70% of the DETGs of miR-1a-3p and miR-195a-5p (a member
of the miR-15 family) were negatively correlated. This supports the
conjecture that the percentage of DETGNCs could be indicative
of a miRNA’s regulatory activity. The highest percentage of
DETGNCs (83%) was recorded for let-7f-5p, let-7g-5p, and miR-
499-5p, which belong to the so-called intronic myomiRs. Based on
their high percentage of DETGNCs, we also identiﬁed miRNAs that
are not yet linked to heart development, namely let-7i (82%),
mir-3472 (79%), and miR-490-3p (73%; also highlighted in
Figure 7. Prioritization of Cardiac miRNAs
(A) Number of differentially expressed targets (DETGs) and differentially expressed genes that are negatively correlated (DETGNCs). Red dots label miRNAs that have been
previously associated with heart development. Blue dots label miRNAs that have not been associated with the heart development to date. Dot size indicates the percentage
of anti-correlated targets, compared to all differentially expressed targets. (B) Examples of two miRNAs (symbolized as diamonds) targeting TFs are shown (squares). Red
borders highlight TFs associated with heart development. The colors of the symbols indicate expression changes in youngmature tissue (shades of red: upregulated; shades
of green: downregulated). (C) Examples of candidates of differentially expressed miRNAs (DEmiRs) targeting differentially expressed genes (DEGs) associated with heart
development are shown.
www.moleculartherapy.orgFigure 7A). These miRNAs can provide attractive leads for further
studies.
In addition, we inspected the number of transcriptional regulators
among the targets of miRNAs. We found 13 miRNAs that target 10
or more transcriptional regulators, with anti-correlated expression
patterns. Differential expression of these miRNAs may have an espe-
cially broad effect on gene expression at a systems level. Strikingly,
miR-1a-3p was the miRNAwith the largest number of anti-correlated
transcription regulators among its potential targets. Among the 18
transcription regulators possibly targeted by miR-1a-3p were six
TFs (Foxp1, Gata6, Hand2, Myocd, Rarb, and Srf) associated with
heart development, supporting a key role for miR-1 in the cardiac
cell lineage (Figure 7B). Other miRNAs targeting multiple transcrip-
tional regulators linked to heart development included miR-362-3p,
miR-132-3p, miR-22-3p, miR-22-5p, and miR-221-3p. Four of the
six transcriptional regulators potentially targeted by miR-22-5p are
associated with heart development in GO, indicating that down-
stream regulatory effects of miR-22-5p may be speciﬁc to cardiogen-
esis (Figure 7B).
Finally, we ﬁltered putative interactions by requiring that both
miRNAs and target genes show at least a 4-fold differential expression
change at one time point and were anti-correlated (Kendall correla-
tion < 0.4). We only included target genes that were already associ-
ated with heart development in GO. Table S11 lists 51 miRNAs that
were identiﬁed as targeting 48 genes annotated as heart develop-
mental genes. Given these stringent thresholds, we retrieved only a
few miRNAs that targeted several genes (e.g., miR-30e-5p targeted
eight genes); the majority targeted only a single gene. However,
miR-22-5p targeted both Tbx20 and Gata4, i.e., two TFs that areessential for heart development (Figure 7C).35 A review of the litera-
ture for these 51 miRNAs showed that 24 (47%) are currently linked
to cardiogenesis or heart functions (Table S12). In this context, their
identiﬁed putative interactions with heart developmental genes may
indicate a speciﬁc role in cardiogenic regulation. More importantly,
we suggest that the remaining 27 miRNAs should be considered as
candidates for cardiac regulators. These includemiR-139-3p targeting
Dicer1, Nedd4, Sox11, and Ednra, as well as miR-540-3p targeting
Nrp2, Caxadr, Heg1, and Ttn (Figure 7C).
HeartMir: An Interactive Resource for Identification of miRNA-
Induced Gene Regulation during Heart Development and
Maturation
We implemented a freely accessible database called HeartMiR, avail-
able at http://heartmir.sysbiolab.eu (Supplemental Information). It
serves as a comprehensive tool for query, visualization, and identiﬁ-
cation of regulatory interactions of miRNAs with potential relevance
in heart development and maturation. Its use is intuitive, following
the scheme outlined in Figure 8. Thus, HeartMiR can be queried
for all interactions of miRNAs and genes or for speciﬁc miRNA-
mRNA interactions. Several gene or miRNA identiﬁers can be used
to deﬁne a query. Currently, accepted gene identiﬁers include the
gene name, gene symbol, Entrez Gene ID (using NCBI annotation),
and its corresponding Affymetrix ID. Identiﬁers for miRNAs, which
can be used for querying, include miRBase, Affymetrix, and Tran-
script IDs. Additionally, a threshold for correlation can be set, result-
ing in the exclusion of interactions with low absolute correlation
between miRNAs and their corresponding target genes. Correlation
of expression is measured using Kendall’s tau coefﬁcient, because
we found the Pearson correlation to be too sensitive to large expres-
sion changes occurring between E19.5 and the young adult stage. TheMolecular Therapy: Nucleic Acids Vol. 12 September 2018 167
Figure 8. Workflow Scheme for HeartMir
Following input of miRNA or gene identifiers (here:Gata4 andmirR-22-5p), HeartMir can be queried for putative miRNA-target gene interactions. All retrieved interactions are
listed in tables, along with additional information. Subsequently, miRNA (mirR-22-5p) and target genes (Tbx20 and Gata4) can be selected and their profiles visualized and
interactively analyzed. Gene expression data are plotted as log2 intensities with or without mean centering. The former provides a more informative presentation of the
absolute expression levels, whereas the latter shows expression changes of transcripts and their (anti-) correlation more clearly.
Molecular Therapy: Nucleic AcidsKendall correlation can be used for the complete time series or with
separate correlation coefﬁcients for developmental time points only
(“Kendall Dev”). This enables a more sensitive examination of how
strongly the expression of miRNAs and their targets are (anti-) corre-
lated during embryonic development (E10.5–E19.5).
The results of all queries are shown in tables. For each of the queried
genes and miRNAs, a separate table displays these interactions, along
with additional information. For experimentally derived interactions,
the relevant PubMed references are given. To facilitate assessment of
predicted interactions and a comparison of their scores, we ranked the
scores and converted them to percentiles for each resource, separately.
Thus, values between 1 and 100 are displayed for computationally pre-
dicted interactions used in HeartMiR. For instance, a value 1 signiﬁes
that the score of the interaction is within the top 1% of all scores for the
corresponding resource; a value of 2 signiﬁes that the score is in top
1%–2%. For gene targets, the result table also indicates whether they
were assigned to processes related to heart development (GO:
0007507) or transcription regulation (GO: 0003700) in GO. These ta-
bles can be interactively sorted and ﬁltered by increasing the threshold
for absolute correlation. Finally, the expression proﬁles of miRNAs
and target genes can be visualized as interactive line plots or heatmaps.
DISCUSSION
At present, there is no comprehensive compendium of heart-associ-
ated miRNAs, neither is there a clear understanding of how they168 Molecular Therapy: Nucleic Acids Vol. 12 September 2018contribute to the development of a fully mature and functional heart.
In addition to providing fundamental biological knowledge, under-
standing their actions on heart development and function might
provide crucial clues for regenerative treatment of heart diseases.35
To facilitate such endeavors, we integrated known or predicted
miRNA-mRNA interactions with expression data from this study.
This resource is available as a user-friendly database (http://
heartmir.sysbiolab.eu/). In order to reduce the transcripts noise
from other cell types interfering with the heart developmental tran-
scripts, we analyzed only transcripts that were up- or downregulated
at least 4-fold at one stage of development.
Our ﬁndings suggest that the composition of cardiac ion channels un-
dergoes major remodeling during development, as many of their
components were differentially expressed during the various stages
of heart development, compared with adult hearts. Among them,
the expression levels of the Cacna2d2 and Cacna1h declined, whereas
the expression of Cacna1g showed reciprocal expression changes dur-
ing heart development. Such remodeling may have physiological rele-
vance, as Cacna1g and Cacna1h encode for the distinct subtypes of
T-type Ca2+ channels: Cav3.1 (a1G) and Cav3.2 (a1H), which are
crucial for electrical conduction in the atria.36 Furthermore, it has
been reported that disruption of Cacna2d2 results in abnormalities
in heart development.37 The expression levels of potassium channels
(Kcna5 and Kcnb1) were very low during all developmental stages but
were strongly upregulated in adult heart tissue. Kcna5 encodes for the
www.moleculartherapy.orgvoltage-gated K+ channel (Kv1.5), which has emerged as a promising
target for the treatment of atrial ﬁbrillation.38,39 The voltage-gated K+
channel KCNB1 is mainly expressed in the heart, brain muscle, and
pancreas40 and is a key player in apoptotic programs associated
with oxidative stress in the cardiovascular system.41 With a transient
maximum at E15.5, Kcna4 displayed a distinctly different pattern that
warrants further investigation, as its role during heart development
has not yet been explored. A similar transient expression maximum
was found for Clca3a1 (Clca1), which encodes for a calcium-activated
chloride channel contributing to the regulation of cellular volume. It
has been speculated that Clca3a1 is involved in arrhythmogenesis of
the heart.42
An interesting by-product of our experimental design was the identi-
ﬁcation of genes that showed gender- or age-dependent expression.
For instance, ATP1A2 was found to be upregulated in old adult
male compared with old adult female heart tissue. It belongs to the
subfamily of Na+/K+-ATPase membrane proteins, regulating the elec-
trochemical gradient in the cardiomyocytes and other cell types by
transporting Na+ and K+ against their intracellular and extracellular
concentrations. Similar upregulation was detected for gelsolin,
Gdf15, members of the Egr and Nr4a protein families, and Pah in
our study. Increased protein levels of gelsolin have previously been
found in several organs of old rats.43 In senescent human ﬁbroblasts,
an enhanced aging-associated resistance to apoptosis was observed
for increased gelsolin expression. GDF15 is a cytokine having
increased expression levels in heart degenerative diseases44 and is
induced under various stress conditions by the early growth response
protein-1 (EGR-1), whose transcript increased in abundance over
time in our study, together with those of its paralogs Egr-2 and
Egr-3. Members of the nuclear receptor subfamily 4, group A are tran-
scriptional regulators of metabolism and energy balance that are
induced by a pleiotropy of stimuli and processes. Recently, it has
been hypothesized that they could serve as targets for anti-aging in-
terventions.45 Analysis of different microarray studies shows that
aging led to consistently increased expression of phenylalanine hy-
droxylase (Pah) in murine hearts.46 In summary, it appears that the
male heart displays higher expression of known age-related marker
genes compared with the female heart. We also identiﬁed genes
that were downregulated in the male heart. These includedMyl7 (en-
codes for myosin light chain 2a) and Myl4 (encodes for myosin light
chain 1), two cardiac-speciﬁc cytoskeletal genes that are key regula-
tors of heart contraction.
Of particular interest are genes encoding for lncRNAs, which are
broadly deﬁned as non-coding transcripts of length of 200 nt or
more. Several lncRNAs are known to play key roles during heart
development and have been associated with the regulation of gene
expression through a variety of mechanisms on transcriptional,
post-transcriptional, and epigenetic levels. In this context, a recent
study identiﬁed a mouse-speciﬁc lncRNA termed Braveheart, ex-
pressed in embryonic stem cells and in mature heart tissue.24 It was
shown that Braveheart strongly enhances the cardiac commitment
by acting as a decoy for SUZ12 (a member of the polycomb repressivecomplex 2 [PRC2]), thereby releasing MESP1 (a master regulator of
cardiac differentiation) from PRC2 suppression. In this study, we
found 25 lncRNAs with signiﬁcant differential expression. Given
the relevance of lncRNAs in gene regulation, this set of lncRNAs pro-
vides an attractive list of candidates for future study.
In addition to TFs and lncRNAs, miRNAs constitute another impor-
tant class of regulators of gene expression. They have pivotal roles in
developmental processes and are implicated in various diseases.
Despite the relatively early association of miRNAs with heart-speciﬁc
expression, a comprehensive capture of miRNA abundance in the
developing heart has never been undertaken. The expression of
miR17-5p was gradually downregulated from E10.5 to E19.5 and
declined again in adult heart tissue (Figure 4). This supports a role
in the regulation of proliferation of cardiac cells, as recently re-
ported.17 Expression in miR-29a-3p, miR-195a-5p, and miR-1a was
relatively low at all developmental stages but was high in adult hearts.
More recently, it has been shown that miR-29-3p is highly upregu-
lated in adult hearts, as well as under pathological conditions,
such as hypertrophic cardiomyopathy.26,27 Expression patterns for
miR-199a-3p and miR-133a showed maxima and minima at develop-
mental stages E12.5 and E13.5, respectively. Expression of miR-
199a-3p has been reported in the adult human heart and is correlated
with heart failure.28,29 In addition, miR199a-3p expression plays a
pivotal role for cardiomyocytes survival.30 The expression of miR-1
also was high in mature hearts compared with all embryonic stages.
Notably, miR-1 belongs to the so called “miR combo” (including
miR-133a) used to reprogram somatic cells in vitro and in vivo.31–33
The expression of the major miRNA candidates obtained in our mi-
croarray study supports their involvement in heart development and
cardiac tissue maintenance.17,32,47–50 Among the miRNAs negatively
correlated with heart development genes, we identiﬁed three miRNAs
belonging to the let7 family (Table S11), which are upregulated during
heart development. It has been previously reported that let7 family
miRs are upregulated in the murine developing heart (E12.5, E14.5,
E16.5, and E18.5; for review, see Bao et al.51).
Surprisingly, more upregulated than downregulated DEmiRs were
detected during heart development. Assuming that the main
regulatory activity of miRNA is post-transcriptional repression,
this suggests that DEmiRs tend to function as suppressors of gene
expression that is characteristic of mature tissue. This is a remark-
able ﬁnding, as we can equally imagine the opposite scenario occur-
ring, where DEmiRs are downregulated to enhance the expression
of target genes that are characteristic for embryonic development.
The consistent overrepresentation of upregulated DEmiRs indicates
that the ﬁrst mode of action is more common during heart develop-
ment. The global analysis of the miRNA transcriptome also revealed
a clear segregation between embryonic and mature tissue samples,
indicating that miRNA expression in the developing heart is sub-
stantially different from the mature heart. Differences between the
late stage of development (E19.5) and mature state deﬁne a frame-
work for expression changes during postnatal maturation. Given
that we detected a large variation between miRNA abundance inMolecular Therapy: Nucleic Acids Vol. 12 September 2018 169
Molecular Therapy: Nucleic Acidsembryonic and mature tissue, we expect that miRNAs contribute
substantially to this maturation process. Indeed, a recent compari-
son of miRNA proﬁles of in vitro derived human cardiomyocytes
identiﬁed a maturation-enhancing role for let-7g.52 The inclusion
of proﬁles of young and old heart tissue in our dataset enabled us
to identify miRNAs that undergo characteristic postnatal changes
and might drive the maturation process. We applied such tem-
plate-based detection to the case of miR-17-5p, which has been
linked to cardiomyocyte proliferation in neonatal and adult cardio-
myocytes, to identify miRNAs that showed similar expression pro-
ﬁles. As shown in Figure S7, miR-122-5p and miR-20a-5p displayed
a very similar expression pattern, with downregulation occurring in
the mature heart. They are predicted to interact with two and six
heart developmental genes, of which two (Bmpr1a and Sox4) and
one (Id1) are also regulators of transcription, as indicated by GO
annotation, respectively. The addition of transcriptome proﬁles
for neonatal and postnatal heart tissue in future studies will help
delineate the different proﬁles during maturation. In general, such
template-based detection could be also applied to other expression
patterns identiﬁed in this study.
The transcriptome study was carried out using a microarray platform,
which has advantages but also limitations compared to RNA
sequencing (RNA-seq) approach. The latter is a newer technology
that is still relatively costly and requires a more complex and time-
consuming process of storing and analyzing of the generated data.53
Also, the transcriptome ﬁndings from RNA-seq can be very much de-
pending on the parameter settings, speciﬁcally for low expressed
genes. On the other hand, a major advantage of the RNA-seq is the
identiﬁcation of longer reads with less starting material.54 Moreover,
RNA-seq can identify previously unknown transcripts in contrast to
the microarrays, which identify only transcripts for which probes
have been included on the microarray.55 Nevertheless, one of the as-
sets of microarrays is the availability of numerous published datasets,
which allows an easy reanalysis and comparison with newly generated
data by other scientists.
Overall, the dual proﬁling of the poly(A)-RNA andmiRNA transcrip-
tome not only provided a comprehensive characterization of murine
heart development but also promises to be an excellent basis to estab-
lish the regulatory molecular networks involved in heart develop-
ment. Our study identiﬁed several miRNAs already reported to be
associated with heart development across different studies,48,49 as
well as many others that appear to be important regulators but are
yet to be explored.56 In creating the open access database and interac-
tive visualization tools implemented in HeartMiR, we provide a
computational resource that will contribute to identiﬁcation of
miRNAs involved in regulating heart development.
MATERIALS AND METHODS
Tissue Collection and Treatment
Fetal hearts were isolated from E10.5 to E19.5 embryos dissected from
OF1 pregnant mice. Young (10-week-old) and old (10-month-old)
adult hearts of OF1 mice were also isolated as completely developed170 Molecular Therapy: Nucleic Acids Vol. 12 September 2018hearts to compare with embryonic stages. At each time point, three
pups were collected as biological replicates in three 1.5-mL micro-
tubes. Biological replicates included hearts from one female pup,
one male pup, and one replicate with mixed male and female hearts
per time point from E12.5 onward. Collection of heart material
from young and old adult mice was carried out similarly. At time
points E10.5 and E11.5, only mixed samples were used, because of
incomplete sex differentiation. Disaggregation of heart tissue was per-
formed by mechanical dissociation, using a tissue homogenization
machine (Precellys24; Bertin Instruments, France). For tissue homog-
enization, 700 mL lysis buffer Trizol (QIAGEN, Hilden, Germany)
was added to each tube and single-cell dissociation was performed
twice, using the Precellys24 for 20 s at 500 rpm. These animal
experiments were approved by the governmental animal care and
use ofﬁce (Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen, Recklinghausen, Germany; reference number
84-02.05.50.15.003).
Microarray Data Processing and Data Quality Assessment
Affymetrix Mouse Genome 430 2.0 arrays and Affymetrix miRNA 3.0
arrays were used to proﬁle gene and miRNA expression during the
mouse embryo cardiogenesis, respectively. RNA from homogenized
heart tissue from different time points was isolated using miRNeasy
mini kits (QIAGEN) with on-column DNase digestion following
the manufacturer’s instructions. Microarray labeling and hybridiza-
tion techniques have been described in detail previously.57
Microarray Data Analysis
Microarray data were processed using the robust multi-array
average (RMA) method on the R/Bioconductor platform. Variability
between samples was visualized using PCA, hierarchical clustering,
and density plots, implemented in R using the entire poly(A)-RNA
and miRNA datasets. For differential expression analysis, the Bio-
conductor package limma58 and multivariate empirical Bayes statis-
tic were applied, enabling comparison of expression values between
different time points.59 To reduce noise in the data, an expression
threshold was set. Genes or miRNA were only considered to be ex-
pressed and included for further analysis when the log2 intensity
produced by RMA for the corresponding probe set was larger
than ﬁve at one time point (at least). The 45101 probe sets on the
Affymetrix Mouse Genome targeted 20,702 genes, with unique En-
trez Gene IDs, of which 11,358 were found be expressed at one time
point (at least). Samples from the 10-week-old adult hearts and
from E19.5 were used as references to calculate differential expres-
sion. To evaluate gender-speciﬁc gene expression, samples from the
same time points were paired and the overall contrast between male
and female samples was calculated. This is analogous to a classical
paired t test. Samples from E12.5 were excluded, as sex differentia-
tion had not been concluded at this stage. Genes were deﬁned as
differentially expressed when the corresponding adjusted p value
was lower than 105 and an absolute log2 fold change in expression
of greater than 2 was recorded. To visualize expression proﬁles in
Figures 2 and 3, the (logged) intensities produced by RMA were in-
verse log2 transformed.
www.moleculartherapy.orgThe full mRNA and miRNA expression datasets have been deposited
in the NCBI Gene Expression Omnibus (GEO GEO: GSE93271).
Clustering and Enrichment Analyses of Differentially Expressed
Genes and miRNAs
To cluster DEGs and DEmiRs, the fuzzy c-means algorithm within
the R/Bioconductor package Mfuzz was used.60 Expression proﬁles
of DEGs and DEmiRs were standardized, i.e., the mean value was
set to zero and the SD was scaled to one for each DEG and DEmiR.
The fuzziﬁcation parameter m was kept at its default value (m = 2).
The number of clusters was selected based on the minimum distance
between cluster centroids (as implemented in the Dmin function of
theMfuzz package), as well as inspection of the visualized cluster pat-
terns. To facilitate interpretation, the cluster index was sorted based
on the cluster proﬁle, starting with downregulated clusters. GO
enrichment analysis for these clusters was carried out in R using
the Bioconductor packages org.Mm.eg.db61 and GOstats.62 To reduce
the number of correlated categories detected as enriched, a hypergeo-
metric test conditioned on the GO tree structure was applied.62
IntegrativeAnalysis of ExpressionData andPotential Regulatory
Interactions
To obtain a comprehensive set of potential miRNA targets, we
collated miRNA-mRNA interactions from ﬁve publically available re-
sources: microRNA.org;63 Pita;64 miRDB;65 TargetScan—providing
computationally predicted interactions;66 and MirTarBase,67 which
included interactions based on experimental evidence. To obtain in-
teractions with high conﬁdence, the computationally predicted inter-
actions were ﬁltered according to recommendations of the creators of
these resources (see Supplemental Information for details). Interac-
tions were discarded when miRs and mRNAs were found not to be
expressed at any time point of the time series. Filtering of interactions
resulted in the identiﬁcation of 102,083 potential interactions between
386 miRNAs and 9,211 target genes. Correlation between mRNAs
and miRNAs was calculated using the Kendall rank correlation,
which provides a more robust measure of the similarity of expression
proﬁles than a standard Pearson correlation.
Statistical Analysis
If not otherwise indicated in the text, the analysis was performed us-
ing a Bayesian moderated t test as implemented in the Bioconductor
package limma and adjusted p values < 105 were considered to be
statistically signiﬁcant.
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